These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 10528114)

  • 21. Levels of Retinal Amyloid-β Correlate with Levels of Retinal IAPP and Hippocampal Amyloid-β in Neuropathologically Evaluated Individuals.
    Schultz N; Byman E; ; Wennström M
    J Alzheimers Dis; 2020; 73(3):1201-1209. PubMed ID: 31884473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Complex Role of Apolipoprotein E in Alzheimer's Disease: an Overview and Update.
    Mahoney-Sanchez L; Belaidi AA; Bush AI; Ayton S
    J Mol Neurosci; 2016 Nov; 60(3):325-335. PubMed ID: 27647307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The interaction of amyloid-beta with ApoE.
    Carter DB
    Subcell Biochem; 2005; 38():255-72. PubMed ID: 15709483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer disease.
    Bertrand P; Poirier J; Oda T; Finch CE; Pasinetti GM
    Brain Res Mol Brain Res; 1995 Oct; 33(1):174-8. PubMed ID: 8774959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A synthetic peptide blocking the apolipoprotein E/beta-amyloid binding mitigates beta-amyloid toxicity and fibril formation in vitro and reduces beta-amyloid plaques in transgenic mice.
    Sadowski M; Pankiewicz J; Scholtzova H; Ripellino JA; Li Y; Schmidt SD; Mathews PM; Fryer JD; Holtzman DM; Sigurdsson EM; Wisniewski T
    Am J Pathol; 2004 Sep; 165(3):937-48. PubMed ID: 15331417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apolipoprotein E co-localizes with newly formed amyloid beta-protein (Abeta) deposits lacking immunoreactivity against N-terminal epitopes of Abeta in a genotype-dependent manner.
    Thal DR; Capetillo-Zarate E; Schultz C; Rüb U; Saido TC; Yamaguchi H; Haass C; Griffin WS; Del Tredici K; Braak H; Ghebremedhin E
    Acta Neuropathol; 2005 Nov; 110(5):459-71. PubMed ID: 16195918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A quantitative and immunohistochemical study on apolipoprotein E in brain tissue in Alzheimer's disease.
    Hesse C; Bogdanovic N; Davidsson P; Blennow K
    Dement Geriatr Cogn Disord; 1999; 10(6):452-9. PubMed ID: 10559559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer's disease is related to the apolipoprotein E genotype.
    Ramassamy C; Averill D; Beffert U; Bastianetto S; Theroux L; Lussier-Cacan S; Cohn JS; Christen Y; Davignon J; Quirion R; Poirier J
    Free Radic Biol Med; 1999 Sep; 27(5-6):544-53. PubMed ID: 10490274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apolipoprotein E (apoE) levels in brains from Alzheimer disease patients and controls.
    Pirttilä T; Soininen H; Heinonen O; Lehtimäki T; Bogdanovic N; Paljärvi L; Kosunen O; Winblad B; Riekkinen P; Wisniewski HM; Mehta PD
    Brain Res; 1996 May; 722(1-2):71-7. PubMed ID: 8813351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variation at the APOE -491 promoter locus is associated with altered brain levels of apolipoprotein E.
    Laws SM; Hone E; Taddei K; Harper C; Dean B; McClean C; Masters C; Lautenschlager N; Gandy SE; Martins RN
    Mol Psychiatry; 2002; 7(8):886-90. PubMed ID: 12232782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preferential deposition of amyloid beta protein (Abeta) in the form Abeta40 in Alzheimer's disease is associated with a gene dosage effect of the apolipoprotein E E4 allele.
    Mann DM; Iwatsubo T; Pickering-Brown SM; Owen F; Saido TC; Perry RH
    Neurosci Lett; 1997 Jan; 221(2-3):81-4. PubMed ID: 9121705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. APOE Effect on Amyloid-β PET Spatial Distribution, Deposition Rate, and Cut-Points.
    Toledo JB; Habes M; Sotiras A; Bjerke M; Fan Y; Weiner MW; Shaw LM; Davatzikos C; Trojanowski JQ;
    J Alzheimers Dis; 2019; 69(3):783-793. PubMed ID: 31127775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxidative balance in Alzheimer's disease: relationship to APOE, Braak tangle stage, and the concentrations of soluble and insoluble amyloid-β.
    Tayler H; Fraser T; Miners JS; Kehoe PG; Love S
    J Alzheimers Dis; 2010; 22(4):1363-73. PubMed ID: 20930272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteome-based plasma markers of brain amyloid-β deposition in non-demented older individuals.
    Thambisetty M; Tripaldi R; Riddoch-Contreras J; Hye A; An Y; Campbell J; Sojkova J; Kinsey A; Lynham S; Zhou Y; Ferrucci L; Wong DF; Lovestone S; Resnick SM
    J Alzheimers Dis; 2010; 22(4):1099-109. PubMed ID: 20930274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amyloid angiopathy and variability in amyloid beta deposition is determined by mutation position in presenilin-1-linked Alzheimer's disease.
    Mann DM; Pickering-Brown SM; Takeuchi A; Iwatsubo T;
    Am J Pathol; 2001 Jun; 158(6):2165-75. PubMed ID: 11395394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apolipoprotein E isoforms in Alzheimer's disease pathology and etiology.
    Baum L; Chen L; Ng HK; Pang CP
    Microsc Res Tech; 2000 Aug; 50(4):278-81. PubMed ID: 10936880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship of APOE, age at onset, amyloid and clinical phenotype in Alzheimer disease.
    Whitwell JL; Tosakulwong N; Weigand SD; Graff-Radford J; Ertekin-Taner N; Machulda MM; Duffy JR; Schwarz CG; Senjem ML; Jack CR; Lowe VJ; Josephs KA;
    Neurobiol Aging; 2021 Dec; 108():90-98. PubMed ID: 34551374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
    Susanto TA; Pua EP; Zhou J;
    J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ApoE epsilon3-haplotype modulates Alzheimer beta-amyloid deposition in the brain.
    Myllykangas L; Polvikoski T; Reunanen K; Wavrant-De Vrieze F; Ellis C; Hernandez D; Sulkava R; Kontula K; Verkkoniemi A; Notkola IL; Hardy J; Perez-Tur J; Haltia MJ; Tienari PJ
    Am J Med Genet; 2002 Apr; 114(3):288-91. PubMed ID: 11920850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apolipoprotein E genotype and its pathological correlation in Chinese Alzheimer's disease with late onset.
    Chen L; Baum L; Ng HK; Chan LY; Pang CP
    Hum Pathol; 1999 Oct; 30(10):1172-7. PubMed ID: 10534164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.